Ratesh Khillan in Brooklyn, New York

Home New York Brooklyn

Ratesh Khillan has Medical Oncology as his primary medical specialty. Their primary office is: 672 Utica Ave in Brooklyn, New York. They attended Sorry, his university is not listed and graduated in 1997 (around 27 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ratesh Khillan Office Phone and Directions

Ratesh Khillan
672 Utica Ave
Brooklyn, New York 11203
718-221-9999

Patient Ratings
Please rate your experience with Ratesh Khillan below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 718-221-9999

Enter a starting address:

Healthcare Info for Ratesh Khillan

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY, INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1997
The Primary Medical Specialty for Ratesh Khillan is listed as: Medical Oncology
Approximate Years of Experience: 27
PAC (PECOS ID)#: 5597803908
NPI #: 1588869374
NPI Created On: 06/20/2007
NPI Last Updated Listed as: 11/21/2022
Primary Taxonomy Code: 282N00000X
License Number:
003427
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Punjabi, Hindi.

Services and Procedures include:

Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, more than 30 minutes
Initial nursing facility visit, typically 35 minutes per day
Subsequent nursing facility visit, typically 15 minutes per day

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435291

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $124

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435295

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435299

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435303

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435311

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435315

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435319

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435327

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788435323

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Medical Oncology Professionals in Brooklyn

1.
Kenneth Csehak

97 Amity St
Brooklyn, NY
New York University

2.
Kenneth Csehak

150 55th St
Brooklyn, NY
New York University

3.
Ramachandra Reddy

374 Stockholm St
Brooklyn, NY
Wyckoff Professional Medical Services Pc

4.
Navjot Dhillon

97 Amity St
Brooklyn, NY
New York University

5.
Navjot Dhillon

150 55th St
Brooklyn, NY
New York University

6.
Salah Almokadem MD

4802 10th Ave
Brooklyn, NY
Mmc Hematology Oncology Fpp

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry